B-Cell Lymphomas Coverage from Every Angle
Advertisement
Advertisement

Ongoing CE Activities

Advances in Lymphoma: Data and Clinical Context From 2021 Summer Meetings
Advances in Targeted Therapy for Relapsed/Refractory DLBCL
An Update on Epigenetic Targets in B- and T-Cell Lymphomas: What Do We Know and Where Are We Going?
Diffuse Large B-Cell Lymphoma: Evolution of Treatment Approaches
Exploring the Current and Changing Paradigm for the Management of Newly Diagnosed Diffuse Large B‑Cell Lymphoma
Follicular Lymphoma Updates for the Oncology Care Team: Data and Clinical Insights
How Are We Integrating New Treatment Strategies Into the Care of Our B-Cell Lymphoma Patients?
Integrating the Latest Evidence on CAR T-Cell Therapy for Non-Hodgkin Lymphoma
Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 6 of an 8-Part Series
Meet The Professor: Optimizing the Clinical Management of Hodgkin and Non-Hodgkin Lymphomas — Part 7 of an 8-Part Series
NCCN Guidelines® Insights - B-Cell Lymphomas, Version 5.2021
Pearls for Interdisciplinary Patient-Centered Care in Hodgkin Lymphoma
Rebooting the BTK Inhibitor Sequence in MCL: Team-Centered Guidance on the Personalized Selection of Covalent and Noncovalent BTK Inhibitors in Relapsed/Refractory Disease
Recorded Presentation From the New NCCN Guidelines for Pediatric Cancers: Management of Pediatric Aggressive Mature B-Cell Lymphoma
Tackling the Complexities of Relapsed/Refractory Follicular Lymphoma: An Update on Recent Advances
Targeted Therapies in B-Cell Malignancies: Management of Adverse Events in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Mantle Cell Lymphoma
Tumor Board on Relapse or Refractory Follicular Lymphoma: Role for Newer Therapies
Understanding CAR T Cells: From Mechanism to Manufacturing
Updates on CAR T-Cell Therapy for Relapsed/Refractory B-Cell Lymphomas
What Clinicians Want to Know: Addressing Current Questions and Controversies in the Management of Hodgkin and Non-Hodgkin Lymphoma
What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update
Clinical Investigator Perspectives on New Data Sets and Advances in Follicular Lymphoma


By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.